Last week the US FDA refused to approve the Moderna mRNA flu vaccine because of the inadequacy of trial design.
Right away the virulence and reach of...
A paper published in the Journal of the American Geriatric Society entitled "Identifying and quantifying potentially problematic prescribing cascades in clinical practice: A mixed-methods study" throws a...
On the Friday before Christmas, Health New Zealand quietly released the 2023 New Zealand cancer data to a media preoccupied with end of year holiday trivia. Not...
Frustrated by questions being raised by some political parties which are currently stalling the Gene Technology Bill, government appointed regulators have gone ahead to...
ChatGPT founder Sam Altman has joined a clutch of tech billionaires contributing to the US$30 million funding of a biotechnology business called Preventive which aims to "correct...
Tom Rutherford, National MP for Bay of Plenty, is described by his party as an exciting young political prospect who is bringing experience and fresh insights...
An Alarming Message for the Royal Commissioners, Media, Medical Authorities, Scientists and MPs
On 26th September 2025 a study entitled “1-year risks of cancers associated...
This article examines what we know about heredity, health and genetics. It draws out the implications for intelligence and the applicability (or rather risks)...
